Education
About Us
Working with TipRanks
Follow Us
Immunome, Inc. (IMNM)
:IMNM
Immunome (IMNM) Ownership Overview
1.46% Insiders
16.18% Mutual Funds
27.34% Other Institutional Investors
9.43% ETFs
45.60% Public Companies and
Individual Investors
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail, and individual investors. Approximately 52.95% of the company’s stock is owned by Institutional Investors, 1.46% is owned by Insiders, and 45.60% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 03, 2025 | Clay Siegall President & Ceo,director | xxxxxxxxxxxxx | $1162500 |
| Nov 25, 2024 | Clay Siegall President & Ceo,director | xxxxxxxxxxxxx | $961807 |
| Nov 25, 2024 | xxxxxxxxxxxxx | $149673 | |
| Nov 25, 2024 | Philip Tsai Cto | xxxxxxxxxxxxx | $198030 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $10417423 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,841,004 | Institution | 4.54% | 33,685,605 | |
| 2,359,760 | Institution | 2.79% | 20,695,095 | |
| 2,318,030 | Institution | 2.74% | 20,329,123 | |
| 1,994,181 | Institution | 2.36% | 17,488,967 | |
| 1,957,102 | Institution | 2.31% | 17,163,785 | |
| 1,692,483 | Institution | 2.00% | 14,843,076 | |
| 1,026,667 | Institution | 1.21% | 9,003,870 | |
| 980,925 | Institution | 1.16% | 8,602,712 | |
| 950,983 | Institution | 1.12% | 8,340,121 | |
| 835,438 | Institution | 0.99% | 7,326,791 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,318,030 | Institution | 2.74% | 20,329,123 | |
| 1,994,181 | Institution | 2.36% | 17,488,967 | |
| 1,957,102 | Institution | 2.31% | 17,163,785 | |
| 1,692,483 | Institution | 2.00% | 14,843,076 | |
| 1,026,667 | Institution | 1.21% | 9,003,870 | |
| 835,438 | Institution | 0.99% | 7,326,791 | |
| 705,181 | Institution | 0.83% | 6,184,437 | |
| 563,956 | Institution | 0.67% | 4,945,894 | |
| 506,173 | Institution | 0.60% | 4,439,137 | |
| 352,282 | Institution | 0.42% | 3,089,513 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,242,522 | Institution | 2.65% | 21,079,707 | |
| 1,386,160 | Institution | 1.64% | 12,156,623 | |
| 1,140,319 | Institution | 1.35% | 10,718,999 | |
| 850,282 | Institution | 1.00% | 7,593,018 | |
| 451,498 | Institution | 0.53% | 3,959,637 | |
| 349,882 | Institution | 0.41% | 3,124,446 | |
| 233,931 | Institution | 0.28% | 2,198,951 | |
| 207,902 | Institution | 0.25% | 1,954,279 | |
| 115,928 | Institution | 0.14% | 1,016,689 | |
| 100,910 | Institution | 0.12% | 884,981 |
FAQ
Who Owns Immunome, Inc. (IMNM)?
According to the latest TipRanks data, approximately 27.34% of the company's stock is held by institutional investors, 1.46% is held by insiders, and 45.60% is held by retail investors.
What percentage of Immunome, Inc. (IMNM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 27.34% of Immunome, Inc. (IMNM) stock is held by institutional investors.
What percentage of Immunome, Inc. (IMNM) stock is held by retail investors?
According to the latest TipRanks data, approximately 45.60% of Immunome, Inc. (IMNM) stock is held by retail investors.
Who owns the most shares of Immunome, Inc. (IMNM)?
Vanguard owns the most shares of Immunome, Inc. (IMNM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.